These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19536122)

  • 1. Addressing the challenges of the clinical application of pharmacogenetic testing.
    Ikediobi ON; Shin J; Nussbaum RL; Phillips KA; ; Walsh JM; Ladabaum U; Marshall D
    Clin Pharmacol Ther; 2009 Jul; 86(1):28-31. PubMed ID: 19536122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic testing in the United Kingdom genetics and immunogenetics laboratories.
    Higgs J; Gambhir N; Ramsden SC; Poulton K; Newman WG
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):121-5. PubMed ID: 20039783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges to integrating pharmacogenetic testing into medication therapy management.
    Haga SB; Allen LaPointe NM; Moaddeb J
    J Manag Care Spec Pharm; 2015 Apr; 21(4):346-52. PubMed ID: 25803768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacogenomics: opportunities and challenges at point of care.
    Scott SA
    Clin Pharmacol Ther; 2013 Jan; 93(1):33-5. PubMed ID: 23212102
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions.
    Marques SC; Ikediobi ON
    Hum Genomics; 2010 Apr; 4(4):238-49. PubMed ID: 20511137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implementation of pharmacogenetics.
    García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
    Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing pharmacogenetic evidence throughout clinical development.
    Burns DK
    Clin Pharmacol Ther; 2010 Dec; 88(6):867-70. PubMed ID: 20981004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalizing medicine with clinical pharmacogenetics.
    Scott SA
    Genet Med; 2011 Dec; 13(12):987-95. PubMed ID: 22095251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.
    Gervasini G; Benítez J; Carrillo JA
    Eur J Clin Pharmacol; 2010 Aug; 66(8):755-74. PubMed ID: 20582584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
    Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
    Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenomics: a new clinical or regulatory paradigm? European experiences of pharmacogenomics in drug regulation and regulatory initiatives.
    Prasad K; Breckenridge A
    Drug Discov Today; 2011 Oct; 16(19-20):867-72. PubMed ID: 21920454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic testing in psychiatry: a review of features and clinical realities.
    de Leon J; Arranz MJ; Ruaño G
    Clin Lab Med; 2008 Dec; 28(4):599-617. PubMed ID: 19059065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative Counseling Considerations for Pharmacogenomic Tests.
    Zierhut HA; Campbell CA; Mitchell AG; Lemke AA; Mills R; Bishop JR
    Pharmacotherapy; 2017 Sep; 37(9):990-999. PubMed ID: 28672074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?
    Soh TI; Yong WP
    Ann Acad Med Singap; 2011 Aug; 40(8):350-5. PubMed ID: 22065000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary care physicians' knowledge of and experience with pharmacogenetic testing.
    Haga SB; Burke W; Ginsburg GS; Mills R; Agans R
    Clin Genet; 2012 Oct; 82(4):388-94. PubMed ID: 22698141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic testing for angiotensin-converting enzyme inhibitors: getting ready for prime time.
    de Denus S
    Pharmacogenomics; 2010 Oct; 11(10):1345-8. PubMed ID: 21047196
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetic testing in psychiatry: not (quite) ready for primetime.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2014 Nov; 52(11):13-6. PubMed ID: 25375387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.